688 related articles for article (PubMed ID: 11925569)
1. Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition.
Mao JR; Taylor G; Dean WB; Wagner DR; Afzal V; Lotz JC; Rubin EM; Bristow J
Nat Genet; 2002 Apr; 30(4):421-5. PubMed ID: 11925569
[TBL] [Abstract][Full Text] [Related]
2. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency.
Schalkwijk J; Zweers MC; Steijlen PM; Dean WB; Taylor G; van Vlijmen IM; van Haren B; Miller WL; Bristow J
N Engl J Med; 2001 Oct; 345(16):1167-75. PubMed ID: 11642233
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of reconstructed human skin on nude mice: a model system to study expression of human tenascin-X and elastic fiber components.
Zweers MC; Schalkwijk J; van Kuppevelt TH; van Vlijmen-Willems IM; Bergers M; Lethias C; Lamme EN
Cell Tissue Res; 2005 Feb; 319(2):279-87. PubMed ID: 15558324
[TBL] [Abstract][Full Text] [Related]
4. Tenascin-X, collagen, elastin, and the Ehlers-Danlos syndrome.
Bristow J; Carey W; Egging D; Schalkwijk J
Am J Med Genet C Semin Med Genet; 2005 Nov; 139C(1):24-30. PubMed ID: 16278880
[TBL] [Abstract][Full Text] [Related]
5. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome.
Burch GH; Gong Y; Liu W; Dettman RW; Curry CJ; Smith L; Miller WL; Bristow J
Nat Genet; 1997 Sep; 17(1):104-8. PubMed ID: 9288108
[TBL] [Abstract][Full Text] [Related]
6. Tenascin-X deficiency and Ehlers-Danlos syndrome: a case report and review of the literature.
O'Connell M; Burrows NP; van Vlijmen-Willems MJ; Clark SM; Schalkwijk J
Br J Dermatol; 2010 Dec; 163(6):1340-5. PubMed ID: 20649799
[TBL] [Abstract][Full Text] [Related]
7. Dermal connective tissue development in mice: an essential role for tenascin-X.
Egging DF; van Vlijmen I; Starcher B; Gijsen Y; Zweers MC; Blankevoort L; Bristow J; Schalkwijk J
Cell Tissue Res; 2006 Mar; 323(3):465-74. PubMed ID: 16331473
[TBL] [Abstract][Full Text] [Related]
8. Wound healing in tenascin-X deficient mice suggests that tenascin-X is involved in matrix maturation rather than matrix deposition.
Egging D; van Vlijmen-Willems I; van Tongeren T; Schalkwijk J; Peeters A
Connect Tissue Res; 2007; 48(2):93-8. PubMed ID: 17453911
[TBL] [Abstract][Full Text] [Related]
9. [The Ehlers-Danlos syndrome: the extracellular matrix scaffold in question].
Fichard A; Chanut-Delalande H; Ruggiero F
Med Sci (Paris); 2003 Apr; 19(4):443-52. PubMed ID: 12836217
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues.
Corsi A; Xu T; Chen XD; Boyde A; Liang J; Mankani M; Sommer B; Iozzo RV; Eichstetter I; Robey PG; Bianco P; Young MF
J Bone Miner Res; 2002 Jul; 17(7):1180-9. PubMed ID: 12102052
[TBL] [Abstract][Full Text] [Related]
11. Mild muscular features in tenascin-X knockout mice, a model of Ehlers-danlos syndrome.
Voermans NC; Verrijp K; Eshuis L; Balemans MC; Egging D; Sterrenburg E; van Rooij IA; van der Laak JA; Schalkwijk J; van der Maarel SM; Lammens M; van Engelen BG
Connect Tissue Res; 2011 Oct; 52(5):422-32. PubMed ID: 21405982
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Molecular Characterization of Classical-Like Ehlers-Danlos Syndrome Due to a Novel
Rymen D; Ritelli M; Zoppi N; Cinquina V; Giunta C; Rohrbach M; Colombi M
Genes (Basel); 2019 Oct; 10(11):. PubMed ID: 31731524
[TBL] [Abstract][Full Text] [Related]
13. Elastic fiber abnormalities in hypermobility type Ehlers-Danlos syndrome patients with tenascin-X mutations.
Zweers MC; Dean WB; van Kuppevelt TH; Bristow J; Schalkwijk J
Clin Genet; 2005 Apr; 67(4):330-4. PubMed ID: 15733269
[TBL] [Abstract][Full Text] [Related]
14. Measurement of serum tenascin-X in patients with congenital adrenal hyperplasia at risk for Ehlers-Danlos contiguous gene deletion syndrome CAH-X.
Kolli V; Kim H; Rao H; Lao Q; Gaynor A; Milner JD; Merke DP
BMC Res Notes; 2019 Oct; 12(1):711. PubMed ID: 31666125
[TBL] [Abstract][Full Text] [Related]
15. Novel
Micale L; Guarnieri V; Augello B; Palumbo O; Agolini E; Sofia VM; Mazza T; Novelli A; Carella M; Castori M
Genes (Basel); 2019 Nov; 10(12):. PubMed ID: 31775249
[No Abstract] [Full Text] [Related]
16. Interactions of human tenascin-X domains with dermal extracellular matrix molecules.
Egging D; van den Berkmortel F; Taylor G; Bristow J; Schalkwijk J
Arch Dermatol Res; 2007 Jan; 298(8):389-96. PubMed ID: 17033827
[TBL] [Abstract][Full Text] [Related]
17. Muscle characteristics and altered myofascial force transmission in tenascin-X-deficient mice, a mouse model of Ehlers-Danlos syndrome.
Huijing PA; Voermans NC; Baan GC; Busé TE; van Engelen BG; de Haan A
J Appl Physiol (1985); 2010 Oct; 109(4):986-95. PubMed ID: 20576846
[TBL] [Abstract][Full Text] [Related]
18. Congenital Adrenal Hyperplasia and Ehlers-Danlos Syndrome.
Marino R; Moresco A; Perez Garrido N; Ramirez P; Belgorosky A
Front Endocrinol (Lausanne); 2022; 13():803226. PubMed ID: 35282436
[TBL] [Abstract][Full Text] [Related]
19. Broadening the Spectrum of Ehlers Danlos Syndrome in Patients With Congenital Adrenal Hyperplasia.
Morissette R; Chen W; Perritt AF; Dreiling JL; Arai AE; Sachdev V; Hannoush H; Mallappa A; Xu Z; McDonnell NB; Quezado M; Merke DP
J Clin Endocrinol Metab; 2015 Aug; 100(8):E1143-52. PubMed ID: 26075496
[TBL] [Abstract][Full Text] [Related]
20. Recurrent pneumothorax in a case of tenascin-X deficient Ehlers-Danlos syndrome: Broadening the phenotypic spectrum.
Santoreneos R; Vakulin C; Ellul M; Rawlings L; Hardy T; Poplawski N
Am J Med Genet A; 2022 May; 188(5):1583-1588. PubMed ID: 35128805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
